Belgium Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Curious about BaaS? Get the full feature comparison in our free eBook comparing the time to create your own cloud backend to a Backend as a Service like Kinvey. From our sponsors

Belgium Pharmaceuticals and Healthcare Report Q4 2013 Sep 18th 2013, 00:00, by swapnil BMI View: Belgium’s pharmaceutical and healthcare markets are struggling in the face of costcontainment measures. However, the government has little choice but to cut back on spending if it is to meet its European fiscal deficit target. Per capita spending on pharmaceuticals is high, and Belgium is an important location for research, clinical trials and new drug development, but drugmakers will increasingly find the government is less willing to reimburse expensive, innovative medicines. Given the ongoing economic troubles in the eurozone, we forecast that Belgium’s pharmaceuticals market will not return to growth until the second half of our 10-year forecast … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116073. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/belgium-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions